Targeting AML Through DR4 With a Novel Variant of rhTRAIL

Journal of Cellular and Molecular Medicine - United Kingdom
doi 10.1111/j.1582-4934.2010.01211.x
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Therapeutic Targeting of Isocitrate Dehydrogenase Mutant AML

Expert Opinion on Investigational Drugs
MedicinePharmacology
2017English

Regulation of a Novel Human Phospholipase C, PLCε, Through Membrane Targeting by Ras

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2000English

IPEX Syndrome in Siblings With a Novel Variant in FOXP3

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Targeting Leukemia Stem Cell-Niche Dynamics: A New Challenge in AML Treatment

Journal of Oncology
Oncology
2019English

A Novel MLPH Variant in Dogs With Coat Colour Dilution

Animal Genetics
Animal ScienceZoologyGeneticsMedicine
2018English

Characterization of a Novel Variant of Mycobacterium Chimaera

Journal of Medical Microbiology
MedicineMicrobiology
2012English

A Novel ABCC6 Variant Causative of Pseudoxanthoma Elasticum

Human Genome Variation
BiochemistryGeneticsMolecular Biology
2019English

Multimodal Imaging in a Pedigree of X-Linked Retinoschisis With a Novel RS1 Variant

BMC Medical Genetics
Genetics
2018English

Adenovirus Type 3 Outbreak in Connecticut Associated With a Novel Variant

Journal of Medical Virology
VirologyInfectious Diseases
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy